Hope on the horizon for 2024 FDA approval of MDMA therapy

MAPS PBC has published anticipated results from its Phase 3b study that could bring MDMA-assisted therapy closer to Food and Drug Administration (FDA) approval by 2024 Phase 3b (MAPP2) study results...